Join the Skin Cancer group to help and get support from people like you.
Skin Cancer News (Page 2)
Related terms: Cancer, Skin
Machine Learning Model Accurately Predicts Survival in Merkel Cell Cancer
WEDNESDAY, Jan. 15, 2025 – A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine....
Diabetes Drug Metformin Protects Against Skin Cancer, New Research Says
TUESDAY, Jan. 14, 2025 – A popular diabetes drug can provide protection against skin cancers, a new study says. Metformin significantly reduces people’s risk of developing basal cell cancers or s...
Thicker Melanoma Tumor Size Tied to Higher Risk of 20-Year Melanoma-Related Death
FRIDAY, Dec. 13, 2024 – Risk of 20-year melanoma-related death increases significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness, according to a study published online Dec. 11...
Characteristics Differ for Melanomas in Children, Teens, Young Adults
TUESDAY, Nov. 26, 2024 – Tumor characteristics differ significantly among pediatric and adolescent and young adult (AYA) patients with melanoma, with decreasing incidence rates seen among young...
Teledermoscopy Accurate for Detecting Skin Cancers
WEDNESDAY, Nov. 20, 2024 – Teledermoscopy has high accuracy for detecting skin cancers, according to a research letter published online Nov. 9 in the Journal of the American Academy of Dermatology....
Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
THURSDAY, Nov. 7, 2024 – There is a negative association between travel time to tanning facilities and county-level melanoma incidence rates, according to a study published online Nov. 7 in the...
Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
THURSDAY, Nov. 7, 2024 – From 1987 to 2016, there was a considerable increase in the incidence of cutaneous malignant melanoma (CMM) among the elderly in the United States, according to a study...
New Set of Risk Factors Can Boost Detection of Suspicious Skin Lesions
MONDAY, Nov. 4, 2024 – A new set of skin cancer risk factors can improve detection of suspicious skin lesions, according to a study published online Sept. 6 in Scientific Reports. Shafiqul Islam,...
A Robot Finger Might Someday Take Your Pulse, Check for Tumors
THURSDAY, Oct. 10, 2024 – A newly developed soft robotic finger with a sophisticated sense of touch could one day help your doctor perform routine office examinations, a new study suggests. The...
Risk for Second Melanoma Up for Those With First Melanoma Diagnosis
WEDNESDAY, Oct. 9, 2024 – Patients with a first melanoma diagnosis have an increased risk for a second melanoma diagnosis, regardless of race and ethnicity, according to a research letter published...
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
WEDNESDAY, Oct. 2, 2024 – Circulating antibodies against cancer-testis antigens (CTAgs) are found in stage I and stage II melanoma plasma samples, according to a study presented at the annual...
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
THURSDAY, Sept. 26, 2024 – Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the...
FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma
September 28, 2018 – The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous...
FDA Approves Mektovi (binimetinib) and Braftovi (encorafenib) in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations
On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib (Braftovi and Mektovi, Array BioPharma Inc.) in combination for patients with unresectable or metastatic...
Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations
BOULDER, Colo., June 27, 2018 /PRNewswire/ – Array BioPharma Inc. (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi capsules in combination with...
Further information
Related condition support groups
Basal Cell Carcinoma, Melanoma, Cancer